Sinopharm Tech Holdings Limited

SEHK:8156 Voorraadrapport

Marktkapitalisatie: HK$18.0m

Sinopharm Tech Holdings Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur2.2yrs

Recente managementupdates

Recent updates

Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?

Feb 02
Is Sinopharm Tech Holdings Limited's (HKG:8156) Shareholder Ownership Skewed Towards Insiders?

How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 29
How Much Did Sinopharm Tech Holdings'(HKG:8156) Shareholders Earn From Share Price Movements Over The Last Five Years?

How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?

Nov 24
How Should Investors Feel About Sinopharm Tech Holdings' (HKG:8156) CEO Remuneration?

CEO

Sinopharm Tech Holdings heeft geen CEO, of we hebben geen gegevens over hen.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kam Kin Ho
Compliance Officer2.2yrsHK$1.47mgeen gegevens
Shuk Yi Kwok
Director of Group Human Resources & Administration and Executive Director2.2yrsHK$1.00mgeen gegevens
Pik Lun Heung
Independent Non-Executive Director1.2yrsgeen gegevensgeen gegevens
Fai Lau
Independent Non-Executive Director4.8yrsHK$104.00kgeen gegevens
Yanjie Cheng
Non-Executive Director5.3yrsHK$104.00k0.043%
HK$ 7.7k
Dong An Hsu
Independent Non-Executive Director1.3yrsgeen gegevensgeen gegevens

2.2yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren bestuur: 8156's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.